drugset / Trial / NCT04622358
A Study to Compare PK, PD and Safety of the AD-214-02 and Rabeprazole
RandomizedCrossoverOpen-labelTreatment
Summary
A study to compare safety, pharmacokinetics and pharmacodynamics of AD-214-02 to Rabeprazole in healthy volunteers.
Timeline
- Start
- 2020-12-05
- Primary completion
- 2021-03-08
- Completion
- 2021-03-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-214-02 | Unknown | — | — |
| Subject | Rabeprazole | Small molecule | — | — |